Univest
Univest
  • Markets

Max Healthcare Institute vs Narayana Hrudayalaya: Which Stock Should You Track

  • August 10, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Max Healthcare Institute vs Narayana Hrudayalaya: Which Stock Should You Track

Max Healthcare MCap Rs 1,05,110 Cr, PE 72.87x, ROE 13.42%, D/E 0.32. Narayana Health MCap Rs 38,878 Cr, PE 47.61x, ROE 17.76%, D/E 1.29.

Max Healthcare vs Narayana Hrudayalaya is a comparison hospital chain investors look up when evaluating two leading Indian private healthcare operators. Max Healthcare is the largest listed multi-speciality hospital chain in North India, operating premium hospitals in Delhi NCR, and has acquired BLK Super Speciality Hospital and Sahara Hospital. Narayana Hrudayalaya is a Bengaluru-based hospital chain founded by cardiac surgeon Dr Devi Shetty, known for providing affordable healthcare at scale, with operations in India and the Cayman Islands.

This Max Healthcare Institute vs Narayana Hrudayalaya article covers reach and market position, key products, latest declared results and stock valuation. The Max Healthcare Institute vs Narayana Hrudayalaya data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.

Table of Contents

Toggle
  • Max Healthcare Institute vs Narayana Hrudayalaya: Reach and Market Position
  • Max Healthcare Institute vs Narayana Hrudayalaya: Key Products and Business Mix
  • Max Healthcare Institute vs Narayana Hrudayalaya: Latest Results
  • Max Healthcare Institute vs Narayana Hrudayalaya: Stock and Valuation
  • Max Healthcare Institute vs Narayana Hrudayalaya: Quick Comparison Table
  • Conclusion
  • Frequently Asked Questions
    • What is Max Healthcare known for?
    • What is Narayana Hrudayalaya known for?
    • What is ARPOB in hospital investing?
    • Does Max Healthcare pay dividends?
    • Which hospital chain has a higher ROE?
    • Is Narayana Hrudayalaya in Nifty 50?
    • How is India’s hospital sector growing?

Max Healthcare Institute vs Narayana Hrudayalaya: Reach and Market Position

On the Max Healthcare Institute side of the Max Healthcare Institute vs Narayana Hrudayalaya comparison, Max Healthcare operates 17 hospitals with 4,500+ beds, primarily in Delhi NCR (Saket, Patparganj, Vaishali, Shalimar Bagh, Mohali) and Kolkata, with recent acquisitions expanding the footprint. Market capitalisation is Rs 1,05,110 Cr.

Click Here – Get Free Investment Predictions

On the Narayana Hrudayalaya side of the Max Healthcare Institute vs Narayana Hrudayalaya comparison, Narayana Hrudayalaya operates 20+ hospitals in India across Bangalore, Kolkata, Ahmedabad and other cities, and a large facility in the Cayman Islands. Known for its low-cost cardiac surgery model. Market capitalisation is Rs 38,878 Cr.

Max Healthcare Institute vs Narayana Hrudayalaya: Key Products and Business Mix

In the Max Healthcare Institute vs Narayana Hrudayalaya product comparison, Max Healthcare Institute offers: Max Healthcare earns from inpatient procedures, OPD and diagnostic services across its North India hospital network. EPS is Rs 14.82. P/E is 72.87x, ROE 13.42 percent, D/E 0.32.

For Narayana Hrudayalaya in this Max Healthcare Institute vs Narayana Hrudayalaya breakdown: Narayana Hrudayalaya earns from cardiac surgeries, multi-speciality procedures and international patients at its Cayman Islands facility. EPS is Rs 39.96. P/E is 47.61x, ROE 17.76 percent, D/E 1.29.

Max Healthcare Institute vs Narayana Hrudayalaya: Latest Results

The Max Healthcare Institute vs Narayana Hrudayalaya results for Max Healthcare Institute: Max Healthcare has a market cap of Rs 1,05,110 Cr and P/E of 72.87x. ROE is 13.42 percent. Max is 2.7 times larger than Narayana by market cap and commands a premium for its North India branded hospital network.

The Max Healthcare Institute vs Narayana Hrudayalaya results for Narayana Hrudayalaya: Narayana Hrudayalaya has a market cap of Rs 38,878 Cr and P/E of 47.61x. ROE is 17.76 percent — higher than Max Healthcare — reflecting its higher bed utilisation and capital-efficient operating model. D/E of 1.29 is elevated for a hospital operator.

Compare Max Healthcare Institute and Narayana Hrudayalaya Fundamentals on the Univest Screener

Max Healthcare Institute vs Narayana Hrudayalaya: Stock and Valuation

The Max Healthcare Institute vs Narayana Hrudayalaya stock comparison uses the latest available market data from Groww. Investors tracking Max Healthcare Institute vs Narayana Hrudayalaya should verify current prices on NSE or BSE before trading.

Max Healthcare vs Narayana Hrudayalaya at current valuations: Max Healthcare trades at Rs 1,05,110 Cr market cap, P/E 72.87x, ROE 13.42 percent. Narayana trades at Rs 38,878 Cr market cap, P/E 47.61x, ROE 17.76 percent, D/E 1.29. Narayana has a higher ROE and lower P/E. Max Healthcare commands a premium for its Delhi NCR brand equity and recent acquisitions.

Max Healthcare Institute vs Narayana Hrudayalaya: Quick Comparison Table

The Max Healthcare Institute vs Narayana Hrudayalaya comparison table below summarises the key metrics covered in this article side by side.

Parameter Max Healthcare Institute Narayana Hrudayalaya
Sector Premium multi-speciality (North India) Affordable multi-speciality + Cayman Islands
Market Cap Rs 1,05,110 Cr Rs 38,878 Cr
P/E Ratio 72.87x 47.61x
ROE 13.42% 17.76%
Debt to Equity 0.32 1.29
Beds 4,500+ (17 hospitals) ~6,000+ (20+ hospitals)
Dividend 0.19% yield 0.24% yield

Conclusion

The Max Healthcare Institute vs Narayana Hrudayalaya comparison above covers the key data points on reach, products, results and valuation. Max Healthcare Institute vs Narayana Hrudayalaya covers two distinct hospital chain models. Max Healthcare Institute vs Narayana Hrudayalaya shows Max as a premium Delhi NCR multi-speciality chain with a high ARPOB and acquisition-led growth. Narayana is known for its high-volume, affordable care model with strong returns from international cardiac patients. Max Healthcare Institute vs Narayana Hrudayalaya each benefit from India’s under-penetrated private healthcare opportunity. Investors reviewing Max Healthcare Institute vs Narayana Hrudayalaya should check ARPOB, occupancy, bed expansion plans and pricing power. Max Healthcare Institute vs Narayana Hrudayalaya represent two complementary healthcare investment thesis — consult a SEBI-registered advisor.

Download the Univest iOS App or Univest Android App to track Max Healthcare Institute and Narayana Hrudayalaya live price and get daily stock recommendations.

SEBI Research Analyst Registration No. INH000013776

Frequently Asked Questions

What is Max Healthcare known for?

Ans. Max Healthcare is known for its premium multi-speciality hospitals in Delhi NCR — Max Smart Super Speciality Hospital Saket, Max Hospital Patparganj, BLK Super Speciality Hospital — offering oncology, cardiac, orthopaedic and transplant services.

What is Narayana Hrudayalaya known for?

Ans. Narayana Hrudayalaya, founded by Dr Devi Shetty, is known for affordable cardiac surgery at scale in India and a large international facility at Health City Cayman Islands. It pioneered high-volume, low-cost cardiac care globally.

What is ARPOB in hospital investing?

Ans. ARPOB stands for Average Revenue Per Occupied Bed. It is the primary efficiency metric for hospital chains, measuring revenue intensity per patient stay. Higher ARPOB with high occupancy implies pricing power and efficiency.

Does Max Healthcare pay dividends?

Ans. Max Healthcare pays a small dividend yield of approximately 0.19 percent.

Which hospital chain has a higher ROE?

Ans. Narayana Hrudayalaya has a higher ROE of 17.76 percent versus Max Healthcare at 13.42 percent, reflecting its more capital-efficient model.

Is Narayana Hrudayalaya in Nifty 50?

Ans. No. Neither Narayana Hrudayalaya nor Max Healthcare is in Nifty 50. Both are tracked in Nifty Healthcare and Nifty 500 indices.

How is India’s hospital sector growing?

Ans. India has a significant under-penetration of private hospital beds relative to WHO standards. Growing urban middle class, health insurance penetration and medical tourism are key demand drivers for premium hospital chains.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply